Journals / Türk Kardiyoloji Derneği Arşivi / 2021 / Cilt: 49 - Sayı: 7

The relationship between plasma proadrenomedullin level and severity of the disease in patients with isolated rheumatic mitral stenosis

zole romatizmal mitral stenozu olan hastalarda plazma proadrenomedullin seviyesi ile hastalık ciddiyeti arasındaki ilişki

Pages
522–532
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The increased NT-proBNP and ProADM levels in patients with isolated rheumatic MS can help clinicians in distinguishing patients with an indication for intervention by providing additional information to echocardiography.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this study, we aimed to determine the plasma proadrenomedullin (ProADM) levels in patients with rheumatic mitral stenosis (MS), to evaluate the relationship between ProADM levels and the echocardiographic parameters that represent the severity of stenosis and symptoms, and to compare the ProADM and N-terminal pro-brain natriuretic peptide (NT-proBNP) levels, which is a well-known marker for rheumatic MS.
📊
Key Findings & Data:Methods: Our study included 53 consecutive patients with isolated rheumatic MS and 45 volunteers with similar age and gender features.
💡
Conclusion & Impact:Conclusion: The increased NT-proBNP and ProADM levels in patients with isolated rheumatic MS can help clinicians in distinguishing patients with an indication for intervention by providing additional information to echocardiography.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: In this study, we aimed to determine the plasma proadrenomedullin (ProADM) levels in patients with rheumatic mitral stenosis (MS), to evaluate the relationship between ProADM levels and the echocardiographic parameters that represent the severity of stenosis and symptoms, and to compare the ProADM and N-terminal pro-brain natriuretic peptide (NT-proBNP) levels, which is a well-known marker for rheumatic MS. Methods: Our study included 53 consecutive patients with isolated rheumatic MS and 45 volunteers with similar age and gender features. Patients with MS were divided into two groups based on the presence of an indication for intervention. Detailed echocardiographic examinations were performed on all participants, and blood samples were collected to detect the NT-proBNP and ProADM levels. Results: NT-proBNP and ProADM levels were significantly higher in the rheumatic MS group compared with the control group. In rheumatic MS groups, patients with an indication for intervention had higher levels of NT-proBNP and ProADM compared with patients without an indication for intervention. Moreover, NT-proBNP and ProADM levels were found to be significantly correlated with echocardiographic parameters, which revealed the severity of stenosis in various degrees. Both parameters increased as the New York Heart Association (NYHA) class increased, and this increase had a statistical significance. Additionally, the cutoff values of both parameters (NT-proBNP: 119.9 pg/mL, ProADM: 6.15 nmol/L) could detect patients with an indication for intervention with high sensitivity and specificity rates. NT-proBNP was found to be slightly more effective in this regard. Conclusion: The increased NT-proBNP and ProADM levels in patients with isolated rheumatic MS can help clinicians in distinguishing patients with an indication for intervention by providing additional information to echocardiography.

Özet

Amaç: Bu çalışmanın amacı romatizmal mitral stenozu (MS) olan hastalarda plazma proadrenomedullin (ProADM) düzeylerini saptamak, ProADM konsantrasyonu ile stenoz ciddiyetinin göstergesi olan ekokardiyografik parametreler ve semptom düzeyi arasındaki ilişkiyi incelemek ve kendini daha önce bu alanda ispatlamış N-terminal pro-brain natriuretic peptide (NT-proBNP) ile ProADM’yi kıyaslamaktır. Yöntemler: Çalışmaya izole romatizmal MS tanısı ile takip ve tedavi altında olan ardışık 53 hasta ile bu hastalarla benzer yaş ve cinsiyet özelliklerine sahip 45 gönüllü dahil edildi. MS haslarında kendi içinde girişim endikasyonu olanlar ve olmayanlar olarak iki gruba ayrıldı. Tüm deneklere detaylı ekokardiyografi yapılıp, NT-proBNP ve ProADM düzeylerinin tespit edilebilmesi için kan örneği alındı. Bulgular: Romatizmal MS’i olan hasta grubunda NT-proBNP ve ProADM seviyesi kontrol grubuna göre anlamı düzeyde daha yüksekti. Benzer şekilde romatizmal MS’i olan hastalar içerisinde girişim endikasyonu olan hastalarda, girişim endikasyonu olmayanlara göre bu iki parametre daha yüksek saptandı (p

🔖

Cite This Article

Kalkan, A. K., Ertürk, M., Yılmaz, E., Uygur, B., Demir, A. R., Çetin, İ., Avcı, Y., Altunova, M. (2022). The relationship between plasma proadrenomedullin level and severity of the disease in patients with isolated rheumatic mitral stenosis. Türk Kardiyoloji Derneği Arşivi, Cilt: 49 - Sayı: 7, 522–532. https://ajindex.com/articles/632376

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Yau TM, El-Ghoneimi YA, Armstrong S, Ivanov J, David TE. Mitral valve repair and replacement for rheumatic disease. J Thorac Cardiovasc Surg 2000
  2. [Crossref] 2. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis 2005
  3. [Crossref] 3. Koratala A, Kazory A. Natriuretic Peptides as Biomarkers for Congestive States: The Cardiorenal Divergence. Dis Markers 2017
  4. 1454986. [Crossref] 4. Abuzaanona A, Lanfear D. Pharmacogenomics of the Natriuretic Peptide System in Heart Failure. Curr Heart Fail Rep 2017
  5. 14(6):536-542. [Crossref] 5. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994
  6. [Crossref] 6. Kargın R, Esen O, Pala S, Akçakoyun M, Emiroğlu Y, Arslan K, et al. The relationship between echocardiographic parameters and brain natriuretic peptide levels in acute and chronic mitral regurgitation. Turk Kardiyol Dern Ars 2011
  7. 39(3):191-7. [Crossref] 7. Davutoglu V, Celik A, Aksoy M, Sezen Y, Soydinc S, Gunay N. Plasma NT-proBNP is a potential marker of disease severity and correlates with symptoms in patients with chronic rheumatic valve disease. Eur J Heart Fail 2005
  8. [Crossref] 8. Kılıçkesmez KO, Bulut G, Başkurt M, Coşkun U, Yıldız A, Küçükoğlu S. QT dispersion in patients with rheumatic mitral stenosis and its relation with echocardiographic findings and serum NT-proBNP levels. Turk Kardiyol Dern Ars 2011
  9. [Crossref] 9. Uslu N, Orhan AL, Nurkalem Z, Avcı İ, Özer HO, Sarı İ, et al. The relationship of high plasma levels of atrial and brain natriuretic peptides with disease severity in mitral valve stenosis. Turk Kardiyol Dern Ars 2006
  10. 34(8):484-488. 10. Minamino N, Kikumoto K, Isumi Y. Regulation of adrenomedullin expression and release. Microsc Res Tech 2002
  11. [Crossref] 11. Tsuruda T, Kato J, Kitamura K, Imamura T, Koiwaya Y, Kangawa K, et al. Enhanced adrenomedullin production by mechanical stretching in cultured rat cardiomyocytes. Hypertension 2000
  12. [Crossref] 12. Baumgartner H, Hung J, Bermejo J, Chambers JB, Edvardsen T, Goldstein S, et al. Recommendations on the Echocardiographic Assessment of Aortic Valve Stenosis: A Focused Update from the European Association of Cardiovascular Imaging and the American So